Showing results (261-270 of 514) with videos related to
Sort By:
Pageof 52
Cancers|September 28, 2023
Treatment of Clival Chordomas: A 20-Year Experience and Systematic Literature ReviewCarolina Noya, Quintino Giorgio D'Alessandris, Francesco Doglietto, et al.Acta Neuropathologica|November 20, 2010
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomasChristian Hartmann, Bettina Hentschel, Wolfgang Wick, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survivalWolfgang Hartmann, Jan Küchler, Arend Koch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?Michael Weller, Hilmar Berger, Christian Hartmann, et al.Journal of Neuro-Oncology|May 19, 2026
APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypesThomas Zeyen, Andreas Decker, Inga Krause, et al.International Journal of Cancer|March 23, 2011
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomasJörg Felsberg, Niklas Thon, Sabina Eigenbrod, et al.Journal of Neuropathology and Experimental Neurology|May 15, 2010
Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutationAchim Temme, Kathrin D Geiger, Ralf Wiedemuth, et al.Journal of Neuro-Oncology|February 13, 2015
Disseminated oligodendroglial-like leptomeningeal tumors: preliminary diagnostic and therapeutic results for a novel tumor entity [corrected]Matthias Preuss, Holger Christiansen, Andreas Merkenschlager, et al.Journal of Personalized Medicine|September 9, 2020
Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of GlioblastomaHassan Rahimi Koshkaki, Simone Minasi, Alessio Ugolini, et al.Brain Tumor Pathology|August 27, 2018
NRASQ61K mutated diffuse leptomeningeal melanomatosis in an adult patient with a brief review of the so-called "forme fruste" of neurocutaneous melanosisIlaria Girolami, Luca Cima, Claudio Ghimenton, et al.Pageof 52